VIRUSLI KASALLIKLARDA IMMUNOLOGIK MODELLARNI TADQIQ ETISH
Keywords:
virusli kasalliklar, immunologik modellar, in vitro modellar, in vivo modellar, matematik modellashtirishAbstract
Ushbu maqolada virusli kasalliklarda immunologik modellarni tadqiq etish masalalari ko'rib chiqiladi. Adabiyotlar tahlili asosida turli immunologik modellar, ularning afzalliklari va cheklovlari muhokama qilinadi. Tadqiqot natijalari zamonaviy immunologik modellarning virusli kasalliklarni o'rganish va davolashda muhim ahamiyatga ega ekanligini ko'rsatadi. Xulosa qismida kelajakdagi tadqiqotlar uchun tavsiyalar beriladi.
References
1.Burrell, C. J., Howard, C. R., & Murphy, F. A. (2017). Fenner and White's Medical Virology. Academic Press.
2.Casadevall, A., & Pirofski, L. A. (2020). The convalescent sera option for containing COVID-19. The Journal of Clinical Investigation, 130(4), 1545-1548.
3.Brinton, M. A., & Gubler, D. J. (2018). Viral Immunology. Clinical Microbiology Reviews, 31(4), e00018-18.
4.Randall, R. E., & Goodbourn, S. (2008). Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. Journal of General Virology, 89(1), 1-47.
5.Gerdts, V., Wilson, H. L., Meurens, F., van Drunen Littel-van den Hurk, S., Wilson, D., Walker, S., ... & Uwiera, R. R. (2015). Large animal models for vaccine development and testing. ILAR Journal, 56(1), 53-62.
6.Perelson, A. S., & Ribeiro, R. M. (2013). Modeling the within-host dynamics of HIV infection. BMC Biology, 11(1), 96.
7.Schutgens, F., & Clevers, H. (2020). Human organoids: tools for understanding biology and treating diseases. Annual Review of Pathology: Mechanisms of Disease, 15, 211-234.
8.Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., ... & Pöhlmann, S. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell, 181(2), 271-280.
